Abstract
Despite level I evidence, no worldwide consensus of opinion exists on how best to manage patients with asymptomatic carotid artery disease. In this article, I present the evidence supporting intervention in these patients, highlighting a number of 'inconvenient truths' that challenge the current 'one size fits all' approach to treatment. I will demonstrate that, even if one could identify and treat every individual with a 60–99% asymptomatic stenosis, >95% of all strokes will still occur. Evidence shows that 94% of all carotid endarterectomy and carotid artery stenting procedures in asymptomatic patients in the US are ultimately unnecessary, costing health-care providers US$2 billion annually. Evidence also exists that the risk of stroke in patients treated medically is lower than when the asymptomatic trials were recruiting, challenging the appropriateness of basing contemporary guidelines upon historical data. A small cohort of 'high-risk for stroke' patients will undoubtedly benefit from intervention and our goal must be to identify and treat these individuals, rather than continuing with a policy of mass intervention that benefits very few patients in the long term.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
European Carotid Surgery Trialists Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet 337, 1235–1243 (1991).
North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N. Engl. J. Med. 325, 445–453 (1991).
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273, 1421–1428 (1995).
Halliday, A. et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 363, 1491–1502 (2004).
Halliday, A. H. et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicenter randomised trial. Lancet 376, 1074–1084 (2010).
Goldstein, L. B. et al. Guidelines for primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42, 517–584 (2011).
Brott, T. G. et al. ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Stroke 16, 35–77 (2011).
Schneider P. A. & Naylor, A. R. Trans-Atlantic debate. Asymptomatic carotid artery stenosis—medical therapy alone versus medical therapy plus carotid endarterectomy or stenting? Eur. J. Vasc. Endovasc. Surg. 40, 274–281 (2010).
Schneider, P. Response to comment regarding trans-Atlantic debate: asymptomatic carotid artery stenosis. Eur. J. Vasc. Endovasc. Surg. 40, 679 (2010).
Wholey, M. H., Barbato, J. E. & Al-Khoury, G. E. Treatment of asymptomatic carotid disease with stenting: pro. Sem. Vasc. Surg. 21, 95–99 (2008).
Naylor, A. R., Rothwell, P. M. & Bell P. R. Overview of the principal results and secondary analyses from the European and the North American randomised trials of endarterectomy for symptomatic carotid stenosis. Eur. J. Vasc. Endovasc. Surg. 26, 115–129 (2003).
Barnett, H. J., Eliasziw, M., Meldrum, H. E. & Taylor, D. W. Do the facts and figures warrant a 10-fold increase in the performance of carotid endarterectomy on asymptomatic patients? Neurology 46, 603–608 (1996).
Chaturvedi, S. Should the multicenter carotid endarterectomy trials be repeated? Arch. Neurol. 60, 774–775 (2003).
Perry, J. R., Szalai, J. P. & Norris, J. W. Consensus against both endarterectomy and routine screening for asymptomatic carotid artery stenosis. Canadian Stroke Consortium. Arch. Neurol. 54, 25–28 (1997).
Abbott, A. Asymptomatic carotid artery stenosis—It's time to stop operating. Nat. Clin. Pract. Neurol. 4, 4–5 (2008).
Abbott, A. L. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke 40, e573–e583 (2009).
Huber, T. S. et al. Effect of the Asymptomatic Carotid Atherosclerosis Study on carotid endarterectomy in Florida. Stroke 29, 1099–1105 (1998).
Moore, W. S. et al. Surgical results: a justification of the surgeon selection process for the ACAS trial. The ACAS investigators. J. Vasc. Surg. 23, 323–328 (1996).
Kresowik T. F. et al. Multistate utilization processes and outcomes of carotid endarterectomy. J. Vasc. Surg. 33, 227–234 (2001).
Bunch, C. T. & Kresowik, T. F. Can randomized trial outcomes for carotid endarterectomy be achieved in community-wide practice? Semin. Vasc. Surg. 17, 209–213 (2004).
Rothwell, P. M. & Goldstein, L. B. Carotid endarterectomy for asymptomatic carotid stenosis: Asymptomatic Carotid Surgery Trial. Stroke 35, 2425–2427 (2004).
Brott, T. G. et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N. Engl. J. Med. 363, 11–23 (2010).
Olsen, T. S. et al. European Stroke Initiative recommendations for stroke management—update 2003. Cerebrovasc. Dis. 16, 311–337 (2003).
Klein, A., Solomon, C. G. & Hamel, M. B. Management of carotid stenosis—polling results. N. Engl. J. Med. 358, e23 (2008).
Barnett, H. J., Pelz, D. M. & Lownie, S. P. Reflections by contrarians on the post-CREST evaluation of carotid stenting for stroke prevention. Int. J. Stroke 5, 455–456 (2010).
Carotid Stenting Guidelines Committee: an Inter-collegiate Committee of the RACP (ANZAN, CSANZ), RACS (ANZSVS) and RANZCR. Guidelines for patient selection and performance of carotid-artery-stenting. Int. Med. J. 41, 344–347 (2011).
Schrooten, M., Fourneau, I., Thijs, V., Verhamme, P. & Nevelsteen, A. Does medical specialty influence the treatment of asymptomatic carotid stenosis? A Belgian multidisciplinary survey. J. Cardiovasc. Surg. 52, 153–157 (2011).
Jayasooriya, G. S., Shalhoub, J., Thapar, A. & Davies, A. H. Patient preference survey in the management of asymptomatic carotid stenosis. J. Vasc. Surg. 53, 1466–1472 (2011).
Rothwell, P. M. ACST: which subgroups will benefit most from carotid endarterectomy? Lancet 364, 1122–1123 (2004).
Young, B. et al. An analysis of perioperative surgical mortality and morbidity in the Asymptomatic Carotid Atherosclerosis Study. Stroke 27, 2216–2224 (1996).
Henriksson, M., Lundgren, F. & Carlsson, P. Cost-effectiveness of endarterectomy in patients with asymptomatic carotid artery stenosis. Br. J. Surg. 95, 714–720 (2008).
Liapis, C. D. et al. ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques. Eur. J. Vasc. Endovasc. Surg. 37 (4 Suppl.), 1–19 (2009).
Chaturvedi, S. et al. Carotid endarterectomy—an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 65, 794–801 (2005).
Wholey, M. H. & Barbato, J. E. Is carotid stenting justified in the asymptomatic patient? Perspectives on indications for CAS. Cath. Cardiovasc. Interv. 69, 1081–1083 (2007).
Baker, W. H., Howard, V. J., Howard, G. & Toole, J. F. for the ACAS Investigators. Effect of contralateral occlusion on long-term efficacy of endarterectomy in the Asymptomatic Carotid Atherosclerosis Study (ACAS). Stroke 31, 2330–2334 (2000).
Naylor, A. R. What is the current status of invasive treatment of extracranial carotid artery disease? Stroke 42, 2080–2085 (2011).
Naylor, A. R., Gaines, P. A. & Rothwell, P. M. Who benefits most from intervention for asymptomatic carotid stenosis: patients or professionals? Eur. J. Vasc. Endovasc. Surg. 37, 625–632 (2009).
Whitty, C. J., Sudlow, C. L. & Warlow, C. P. Investigating individual subjects and screening populations for asymptomatic carotid stenosis can be harmful. J. Neurol. Neurosurg. Psych. 64, 619–623 (1998).
Redberg, R. F. Squandering Medicare's Money. New York Times (25 May 2011).
Naylor AR, Gaines, PA Rothwell PM. Corrigendum to “Who benefits most from intervention for asymptomatic carotid stenosis: patients or professionals?” [Eur. J. Vasc. Endovasc. Surg. 37, 625–632 (2009).]. Eur. J. Vasc. Endovasc. Surg. 38, 657 (2009).
McPhee, J. T., Schanzer, A., Messina, L. M. & Eslami, M. H. Carotid artery stenting has increased rates of postprocedure stroke, death and resource utilization than does carotid endarterectomy in the United States, 2005. J. Vasc. Surg. 48, 1442–1450 (2008).
Kadoglou, N. P. et al. Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis. Eur. J. Vasc. Endovasc. Surg. 35, 661–668 (2008).
Spence, J. D. et al. Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch. Neurol. 67, 180–186 (2010).
Nicolaides, A. N. et al. Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS study. Eur. J. Vasc. Endovasc. Surg. 30, 275–284 (2005).
Sabeti, S. et al. Progression of carotid stenosis detected by duplex ultrasonography predicts adverse outcomes in cardiovascular high-risk patients. Stroke 38, 2887–2894 (2007).
Kakkos, S. K. et al. Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery stenosis. J. Vasc. Surg. 49, 902–909 (2009).
Nicolaides, A. N. et al. Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification. J. Vasc. Surg. 52, 1486–1496 (2010).
Griffin, M., Nicolaides, A. & Kyriacou, E. Normalisation of ultrasonic images of atherosclerotic plaques and reproducibility of gray scale median using dedicated software. Int. Angiol. 26, 372–377 (2007).
Geroulakos, G. et al. Characterization of symptomatic and asymptomatic carotid plaques using high-resolution, real-time ultrasonography. Br. J. Surg. 80, 1274–1277 (1993).
Griffin, M. B. et al. Juxtaluminal hypoechoic area in ultrasonic images of carotid plaques and hemispheric symptoms. J. Vasc. Surg. 52, 69–76 (2010).
Tegos, T. J. et al. Types of neurovascular symptoms and carotid plaque ultrasonic textural characteristics. J. Ultrasound. Med. 20, 113–121 (2011).
Nicolaides, A. N. et al. Effect of image normalization on carotid plaque classification and the risk of ipsilateral hemispheric ischemic events: results from the Asymptomatic Carotid Stenosis and Risk of Stroke study. Vascular 13, 211–221 (2005).
Ringelstein, E. B. et al. Consensus on microembolus detection by TCD. International Consensus Group on Microembolus Detection. Stroke 29, 725–729 (1998).
Markus, H. S. et al. Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Lancet Neurol. 9, 663–671 (2010).
Spence, J. D. et al. Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch. Neurol. 67, 180–186 (2010).
Takaya, N. et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI—initial results. Stroke 37, 818–823 (2006).
Singh, N. et al. Moderate carotid artery stenosis: MR imaging-depicted intraplaque hemorrhage predicts risk of cerebrovascular ischemic events in asymptomatic men. Radiology 252, 502–508 (2009).
Johnson, J. M., Kennelly, M. M., Decesare, D., Morgan, S. & Sparrow, A. Natural history of asymptomatic carotid plaque. Arch. Surg. 120, 1010–1012 (1985).
Chambers, B. R. & Norris, J. W. Outcome in patients with asymptomatic neck bruits. N. Engl. J. Med. 315, 860–865 (1986).
Satiani, B., Porter, R. M. Jr., Biggers, K. M. & Das, B. M. Natural history of nonoperated significant carotid stenosis. Ann. Vasc. Surg. 2, 271–278 (1988).
Norris, J. W., Zhu, C. Z., Bornstein, N. M. & Chambers, B. R. Vascular risks of asymptomatic carotid disease. Stroke 22, 1485–1490 (1991).
Bock, R. W. et al. The natural history of asymptomatic carotid artery disease. J. Vasc. Surg. 17, 160–169 (1993).
Hobson, R. W. et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. N. Engl. J. Med. 328, 221–227 (1993).
Côté, R. et al. Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. The Asymptomatic Cervical Bruit Study Group. Ann. Int. Med. 123, 649–655 (1995).
ECST Trialists Collaborative Group. Risk of stroke in the distribution of an asymptomatic carotid artery. Lancet 345, 209–212 (1995).
Mackey, A. E. et al. Outcome of asymptomatic patients with carotid disease. Asymptomatic Cervical Bruit Study Group. Neurology 48, 896–903 (1997).
Inzitari, D. et al. Causes and risk of stroke patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N. Engl. J. Med. 342, 1693–1700 (2000).
Goessens, B. M. et al. Asymptomatic carotid artery stenosis and the risk of new vascular events in patients with manifest arterial disease: the SMART study. Stroke 38, 1470–1475 (2007).
Marquardt, L., Geraghty, O. C., Mehta, Z. & Rothwell, P. M. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke 41, e11–e17 (2010).
Hankey, G. J. Asymptomatic carotid stenosis: how should it be managed? Med. J. Aust. 163, 197–200 (1995).
Hertzer, N. R. A personal view: the Asymptomatic Carotid Atherosclerosis Study results—read the label carefully. J. Vasc. Surg. 23, 167–171 (1996).
Inzitari, D. et al. The causes and risk of stroke patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N. Engl. J. Med. 342, 1693–1700 (2000).
US Preventive Services Task Force. Screening for carotid artery stenosis: US Preventive Services Task Force Recommendation Statement. Ann. Int. Med. 147, 854–859 (2007).
Arazi, H. C. et al. Carotid endarterectomy in asymptomatic stenosis: a decision analysis. Clin. Neurol. Neurosurg. 110, 472–479 (2008).
Rothwell, P. M. Carotid stenting: more risky than endarterectomy and often no better than medical treatment alone. Lancet 375, 957–959 (2010).
Brott, T. Asymptomatic carotid disease: where do we go from here? Vascular News 4–6 (January 2010).
Abbott, A. L. et al. Embolic signals and prediction of ipsilateral stroke or TIA in asymptomatic carotid stenosis: a multicenter prospective cohort study. Stroke 36, 1128–1133 (2005).
Molloy, J. & Markus, H. S. Asymptomatic embolization predicts stroke and TIA risk in patients with carotid artery stenosis. Stroke 30, 1440–1443 (1999).
Orlandi, G., Fanucchi, S., Sartucci, F. & Murri, L. Can microembolic signals identify unstable plaques affecting symptomatology in carotid stenosis? Stroke 33, 1744–1746 (2002).
Siebler, M. et al. Cerebral microembolism and the risk of ischemia in asymptomatic high-grade internal carotid artery stenosis. Stroke 26, 2184–21886 (1995).
Spence, J. D., Tamayo, A., Lownie, S. P., Ng, W. P. & Ferguson, G. G. Absence of microemboli on transcranial Doppler identifies low-risk patients with asymptomatic carotid stenosis. Stroke 36, 2373–2378 (2005).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Naylor, A. Time to rethink management strategies in asymptomatic carotid artery disease. Nat Rev Cardiol 9, 116–124 (2012). https://doi.org/10.1038/nrcardio.2011.151
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2011.151
This article is cited by
-
Development of Molecular Magnetic Resonance Imaging Tools for Longitudinal Tracking of Carotid Atherosclerotic Disease Using Fast Imaging with Steady-State Precession
Translational Stroke Research (2023)
-
The 2nd European Carotid Surgery Trial (ECST-2): rationale and protocol for a randomised clinical trial comparing immediate revascularisation versus optimised medical therapy alone in patients with symptomatic and asymptomatic carotid stenosis at low to intermediate risk of stroke
Trials (2022)
-
Effectiveness of an individualized home-based physical activity program in surgery-free non-endarterectomized asymptomatic stroke patients: a study protocol for the PACAPh interventional randomized trial
Trials (2022)
-
Motion synchronisation patterns of the carotid atheromatous plaque from B-mode ultrasound
Scientific Reports (2020)
-
Management of Patients with an Asymptomatic Carotid Stenosis—Medical Management, Endovascular Treatment, or Carotid Endarterectomy?
Current Neurology and Neuroscience Reports (2016)